AMMJ — American Cannabis Income Statement
0.000.00%
Last trade - 00:00- $0.20m
- $0.78m
- $2.48m
Annual income statement for American Cannabis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.13 | 1.57 | 2.43 | 18.8 | 2.48 |
| Cost of Revenue | |||||
| Gross Profit | 1.34 | 0.721 | 1.06 | 2.54 | 1.04 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.15 | 2.19 | 3.82 | 19.4 | 6.33 |
| Operating Profit | -0.02 | -0.624 | -1.4 | -0.606 | -3.85 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.302 | -0.532 | -1.44 | -0.633 | -3.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.302 | -0.532 | -1.44 | -0.633 | -3.66 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.302 | -0.532 | -1.44 | -0.633 | -3.66 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.302 | -0.532 | -1.44 | -0.633 | -3.66 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.006 | -0.009 | -0.017 | -0.007 | -0.021 |